Expression characteristic of 4Ig B7-H3 and 2Ig B7-H3 in acute myeloid leukemia

References

• Khwaja A, Bjorkholm M, Gale RE, et al. Acute myeloid leukaemia. Nat Rev Dis Primers. 2016;2:16010.
   PubMed Web of Science ®Google Scholar
• Kadia TM, Ravandi F, Cortes J, et al. Toward individualized therapy in acute myeloid leukemia: a contemporary review. JAMA Oncol. 2015;1:820–828.
   PubMed Web of Science ®Google Scholar
• DiNardo CD, Wei AH. How I treat acute myeloid leukemia in the era of new drugs. Blood. 2020;135:85–96.
   PubMed Web of Science ®Google Scholar
• Nair R, Salinas-Illarena A, Baldauf HM. New strategies to treat AML: novel insights into AML survival pathways and combination therapies. Leukemia. 2021;35:299–311.
   PubMed Web of Science ®Google Scholar
• Steinberger P, Majdic O, Derdak SV, et al. Molecular characterization of human 4Ig-B7-H3, a member of the B7 family with four Ig-like domains. J Immunol. 2004;172:2352–2359.
   PubMed Web of Science ®Google Scholar
• Zhou YH, Chen YJ, Ma ZY, et al. 4IgB7-H3 is the major isoform expressed on immunocytes as well as malignant cells. Tissue Antigens. 2007;70:96–104.
   PubMedGoogle Scholar
• Sun J, Fu F, Gu W, et al. Origination of new immunological functions in the costimulatory molecule B7-H3: the role of exon duplication in evolution of the immune system. PLoS One. 2011;6:e24751.
   PubMed Web of Science ®Google Scholar
• Chapoval AI, Ni J, Lau JS, et al. B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production. Nat Immunol. 2001;2:269–274.
   PubMed Web of Science ®Google Scholar
• Picarda E, Ohaegbulam KC, Zang X. Molecular pathways: targeting B7-H3 (CD276) for human cancer immunotherapy. Clin Cancer Res. 2016;22:3425–3431.
   PubMed Web of Science ®Google Scholar
• Zhang W, Wang J, Wang Y, et al. B7-H3 silencing by RNAi inhibits tumor progression and enhances chemosensitivity in U937 cells. Onco Targets Ther. 2015;8:1721–1733.
   PubMed Web of Science ®Google Scholar
• Hu Y, Lv X, Wu Y, et al. Expression of costimulatory molecule B7-H3 and its prognostic implications in human acute leukemia. Hematology. 2015;20:187–195.
   PubMed Web of Science ®Google Scholar
• Sun X, Tian Y, Wang J, et al. Genome-wide analysis reveals the association between alternative splicing and DNA methylation across human solid tumors. BMC Med Genomics. 2020;13:4.
   PubMed Web of Science ®Google Scholar
• Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;114:937–951.
   PubMed Web of Science ®Google Scholar
• Zhang ZH, Zhang W, Zhou JD, et al. Decreased SCIN expression, associated with promoter methylation, is a valuable predictor for prognosis in acute myeloid leukemia. Mol Carcinog. 2018;57:735–744.
   PubMed Web of Science ®Google Scholar
• O’Donnell MR, Abboud CN, Altman J, et al. NCCN clinical practice guidelines acute myeloid leukemia. J Natl Compr Canc Netw. 2012;10:984–1021.
   PubMed Web of Science ®Google Scholar
• Tallman MS, Wang ES, Altman JK, et al. Acute myeloid leukemia, version 3.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2019;17:721–749.
   PubMed Web of Science ®Google Scholar
• Zhang W, Wang J, Wang YF, et al. [Expression and subcellular distribution of costimulatory molecules B7-H1,B7-H3 and B7-H4 in human hematologic malignancy cell lines]. J Exp Hematol. 2016;24:1539–1546.
   Google Scholar
• Guery T, Roumier C, Berthon C, et al. B7-H3 protein expression in acute myeloid leukemia. Cancer Med. 2015;4:1879–1883.
   PubMed Web of Science ®Google Scholar
• Sun M, Richards S, Prasad DV, et al. Characterization of mouse and human B7-H3 genes. J Immunol. 2002;168:6294–6297.
   PubMed Web of Science ®Google Scholar
• Xu H, Cheung IY, Guo HF, et al. MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: potential implications for immune based therapy of human solid tumors. Cancer Res. 2009;69:6275–6281.
   PubMed Web of Science ®Google Scholar
• Chen C, Shen Y, Qu QX, et al. Induced expression of B7-H3 on the lung cancer cells and macrophages suppresses T-cell mediating anti-tumor immune response. Exp Cell Res. 2013;319:96–102.
   PubMed Web of Science ®Google Scholar
• Sun TW, Gao Q, Qiu SJ, et al. B7-H3 is expressed in human hepatocellular carcinoma and is associated with tumor aggressiveness and postoperative recurrence. Cancer Immunol Immunother. 2012;61:2171–2182.
   PubMed Web of Science ®Google Scholar
• Inamura K, Takazawa Y, Inoue Y, et al. Tumor B7-H3 (CD276) expression and survival in pancreatic cancer. J Clin Med. 2018;7:172.
   PubMed Web of Science ®Google Scholar
• Zhang T, Wang F, Wu JY, et al. Clinical correlation of B7-H3 and B3GALT4 with the prognosis of colorectal cancer. World J Gastroenterol. 2018;24:3538–3546.
   PubMed Web of Science ®Google Scholar
• Wang Z, Yang J, Zhu Y, et al. Differential expression of 2IgB7-H3 and 4IgB7-H3 in cancer cell lines and glioma tissues. Oncol Lett. 2015;10:2204–2208.
   PubMed Web of Science ®Google Scholar
• Wouters BJ, Delwel R. Epigenetics and approaches to targeted epigenetic therapy in acute myeloid leukemia. Blood. 2016;127:42–52.
   PubMed Web of Science ®Google Scholar
• Giacopelli B, Wang M, Cleary A, et al. DNA methylation epitypes highlight underlying developmental and disease pathways in acute myeloid leukemia. Genome Res. 2021;31:747–761.
   PubMed Web of Science ®Google Scholar
• Wang Z, Wang Z, Zhang C, et al. Genetic and clinical characterization of B7-H3 (CD276) expression and epigenetic regulation in diffuse brain glioma. Cancer Sci. 2018;109:2697–2705.
   PubMed Web of Science ®Google Scholar
• Tang J, Jiang W, Liu D, et al. The comprehensive molecular landscape of the immunologic co-stimulator B7 and TNFR ligand receptor families in colorectal cancer: immunotherapeutic implications with microsatellite instability. Oncoimmunology. 2018;7:e1488566.
   PubMed Web of Science ®Google Scholar
• Yang Q, Cao W, Wang Z, et al. Regulation of cancer immune escape: the roles of miRNAs in immune checkpoint proteins. Cancer Lett. 2018;431:73–84.
   PubMed Web of Science ®Google Scholar
• Zhu XW, Wang J, Zhu MX, et al. MicroRNA-506 inhibits the proliferation and invasion of mantle cell lymphoma cells by targeting B7H3. Biochem Biophys Res Commun. 2019;508:1067–1073.
   PubMed Web of Science ®Google Scholar
• Zhao X, Li DC, Zhu XG, et al. B7-H3 overexpression in pancreatic cancer promotes tumor progression. Int J Mol Med. 2013;31:283–291.
   PubMed Web of Science ®Google Scholar
• Zhang W, Wang Y, Wang J, et al. B7-H3 silencing inhibits tumor progression of mantle cell lymphoma and enhances chemosensitivity. Int J Oncol. 2015;46:2562–2572.
   PubMed Web of Science ®Google Scholar